当前位置: X-MOL 学术Proc. Natl. Acad. Sci. U.S.A. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction for Emerling et al., Identification of CDCP1 as a hypoxia-inducible factor 2{alpha} (HIF-2{alpha}) target gene that is associated with survival in clear cell renal cell carcinoma patients [Corrections]
Proceedings of the National Academy of Sciences of the United States of America ( IF 9.4 ) Pub Date : 2021-08-10 , DOI: 10.1073/pnas.2112097118
National Academy of Sciences

MEDICAL SCIENCES Correction for “Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients,” by Brooke M. Emerling, Cyril H. Benes, George Poulogiannis, Eric L. Bell, Kevin Courtney, Hui Liu, Rayman Choo-Wing, Gary Bellinger, Kazumi S. Tsukazawa, Victoria Brown, Sabina Signoretti, Stephen P. Soltoff, and Lewis C. Cantley, which was first published February 1, 2013; 10.1073/pnas.1222435110 (Proc. Natl. Acad. Sci. U.S.A. 110, 3483–3488).

中文翻译:

Emerling 等人的更正,CDCP1 作为缺氧诱导因子 2{alpha} (HIF-2{alpha}) 靶基因的鉴定,与透明细胞肾细胞癌患者的存活相关 [更正]

医学科学对“CDCP1 作为缺氧诱导因子 2α (HIF-2α) 靶基因与透明细胞肾细胞癌患者的存活相关的鉴定”的校正,作者Brooke M. Emerling、Cyril H. Benes、George Poulogiannis, Eric L. Bell、Kevin Courtney、Hui Liu、Rayman Choo-Wing、Gary Bellinger、Kazumi S. Tsukazawa、Victoria Brown、Sabina Signoretti、Stephen P. Soltoff 和 Lewis C. Cantley,于 2013 年 2 月 1 日首次出版;10.1073/pnas.1222435110(Proc. Natl. Acad. Sci. USA 110 , 3483–3488)。
更新日期:2021-08-02
down
wechat
bug